Quick Answer
GUIDED THERAPEUTICS INC reported Net Income of -$3.20 million for fiscal year 2025.
GUIDED THERAPEUTICS INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$3.20M | -32.2% |
| 2024 | -$2.42M | +30.7% |
| 2023 | -$3.49M | +19.6% |
| 2022 | -$4.34M | -109.7% |
| 2021 | -$2.07M | -641.9% |
| 2020 | -$279.0K | +85.5% |
| 2019 | -$1.92M | -289.1% |
| 2018 | $1.02M | +109.5% |
| 2017 | -$10.70M | -169.4% |
| 2016 | -$3.97M | +42.5% |
| 2015 | -$6.90M | +30.2% |
| 2014 | -$9.88M | -37.0% |
| 2013 | -$7.21M | -65.7% |
| 2012 | -$4.35M | +34.5% |
| 2011 | -$6.64M | -133.5% |
| 2010 | -$2.85M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$742.0K | -13.5% | +8.5% |
| June 30, 2025 | -$811.0K | -14.4% | -189829.7% |
| March 31, 2025 | -$427.00 | -6.2% | +99.9% |
| September 30, 2024 | -$654.0K | +3.4% | +7.8% |
| June 30, 2024 | -$709.0K | +54.5% | -176268.2% |
| March 31, 2024 | -$402.00 | +100.0% | +99.9% |
| September 30, 2023 | -$677.0K | +38.6% | +56.5% |
| June 30, 2023 | -$1.56M | -68.1% | -79.2% |
- GUIDED THERAPEUTICS INC showed a decrease of -32.2% in Net Income compared to the prior fiscal year.
- Over the 2010–2025 period, GUIDED THERAPEUTICS INC’s net income has declined by 12.3% (from -$2.85 million to -$3.20 million).
- The most recent figure is from GUIDED THERAPEUTICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: